About: analysis

Documentation

scienceplus.abes.fr version Bêta

scienceplus.abes.fr | explorer

À propos de : analysis Goto Sponge NotDistinct Permalink

Attributs	Valeurs
type	Concept
rdfs:label	analysis Analysis
skos:inScheme	http://hub.abes.fr/referentiel/bmjarticlecategories
is Subject of	Screening programmes for chlamydial infection: when will we ever learn? Time to move towards opt-out testing for HIV in the UK Commentary: Health inequity could increase in poor countries if universal HPV vaccination is not adopted Use of process measures to monitor the quality of clinical practice Support for self care for patients with chronic disease Shifting the focus in fracture prevention from osteoporosis to falls Is the declaration of Alma Ata still relevant to primary health care? How can quality of health care be safeguarded across the European Union? GRADE: an emerging consensus on rating quality of evidence and strength of recommendations Autonomy, stress, and treatment of depression Founding principles Moving forward on rationing: an economic view What are the prospects of stem cell therapy for neurology? Meeting the challenge of antibiotic resistance Breast screening: the facts—or maybe not Neuraminidase inhibitors—the story behind the Cochrane review Are advance directives legally binding or simply the starting point for discussion on patients’ best interests? Ethical view Commentary: journals must facilitate the dissemination and scrutiny of clinical research What do we mean by Alzheimer’s disease? Childhood protection and obesity: framework for practice Unanswered questions over NHS health checks How should we balance individual and population benefits of statins for preventing cardiovascular disease? Strengthening primary healthcare in India: white paper on opportunities for partnership Could NICE guidance on the choice of blood pressure lowering drugs be simplified? Commentary: Denmark’s health reforms are part of a wider trend Transcatheter aortic valve implantation (TAVI): risky and costly Humanism in the time of metrics—an essay by David Loxterkamp Medicalising unhappiness: new classification of depression risks more patients being put on drug treatment from which they will not benefit Sudden exertional death in sickle cell trait Designing and evaluating complex interventions to improve health care Getting services right for those sick enough to die Functional foods: the case for closer evaluation Routine testing to reduce late HIV diagnosis in France Commentary: The balance between marketing and safety Tackling malaria today Reappraising Florence Nightingale Communicating about screening Students whose behaviour causes concern: Case history Screening for prostate cancer remains controversial Can quality and productivity improve in a financially poorer NHS? Challenges for WHO code on international recruitment New drugs for old: disinvestment and NICE Malaria control beyond 2010 Can user charges make health care more efficient? Mentally disordered or lacking capacity? Lessons for management of serious deliberate self harm Data availability for industry sponsored trials: what should medical journals require? Can the government’s proposals for NHS reform be made to work? Commentary: Unintended consequences of governance Ethics and effectiveness: rationing healthcare by thresholds of minimum effectiveness The idolatry of the surrogate Ecological public health: the 21st century’s big idea? An essay by Tim Lang and Geof Rayner Deficiencies in proposed new EU regulation of clinical trials An unblinkered view of best interests The Quality and Outcomes Framework—where next? Commentary: Opportunities to prevent fracture are being missed What should follow the millennium development goals? Restructuring health systems for an era of prolonged austerity: an essay by Richard B Saltman and Zachary Cahn Towards sustainable clinical trials When professional opinion is not enough Unequal weight: equity oriented policy responses to the global obesity epidemic Best interests and potential organ donors Has the time come to take on time itself? Clinical priority setting Patients and the public deserve big changes in evaluation of drugs Journal of another plague year Lessons from the past decade for future health reforms Publishing information about ongoing clinical trials for patients How New Zealand has contained expenditure on drugs Using hospital mortality rates to judge hospital performance: a bad idea that just won’t go away Commentary: Knowledge is not always power What do patients want of performance information? Commentary: but what should journals actually do to keep industry sponsored research unbiased? An alternative to the war on drugs Quality of care in frail older people: the fragile balance between receiving and giving EMA must improve the quality of its clinical trial reports Challenges of EU competition law for general practice commissioning Challenges of drug resistance in the developing world Global threat from drug resistant HIV in sub-Saharan Africa Why the US healthcare system is failing, and what might rescue it Problems of stopping trials early Shared decision making: really putting patients at the centre of healthcare NICE hypertension guideline 2011: evidence based evolution Why corporate power is a public health priority Raising the bar for market authorisation of new drugs How to achieve international action on falsified and substandard medicines NICE’s end of life decision making scheme: impact on population health Women prisoners Commentary: Europe needs a central, transparent, and evidence based regulation process for devices New polyps, old tricks: controversy about removing benign bowel lesions Should people at low risk of cardiovascular disease take a statin? The in-between world of knowledge brokering Preventive health care in elderly people needs rethinking Drugs for pre-osteoporosis: prevention or disease mongering? Widening participation in medicine Universality, equity, and quality of care Regulation—the real threat to clinical research

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata